{
    "title": "Acelyrin tumbles after skin disease drug fails key trial",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-12508567/Acelyrin-tumbles-skin-disease-drug-fails-key-trial.html",
    "date": "2023-09-12",
    "keywords": [
        "drug",
        "trial",
        "acelyrin",
        "companys",
        "skin",
        "price",
        "company",
        "developer",
        "premarket",
        "trading",
        "tuesday",
        "disease",
        "opening",
        "bell",
        "offering",
        "ipo",
        "sector",
        "year",
        "funding",
        "crunch",
        "biotech",
        "midtolate",
        "stage",
        "izokibep",
        "hidradenitis",
        "suppurativa",
        "inflammatory",
        "condition",
        "goal",
        "reduction",
        "placebo",
        "increase",
        "analyst",
        "tewari",
        "target",
        "stock",
        "clarity",
        "path",
        "forward",
        "reporting",
        "santhosh",
        "bengaluru",
        "editing",
        "saumyadeb",
        "chakrabarty"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}